Therefore, a deep understanding of the remodeling mechanism of cellular composition and molecular characteristics in the EGFR/TP53 co-mutated NSCLC tumor microenvironment (TME) is of great significance for identifying new targets for immunotherapy intervention. This evidence concerns the gene TP53 and non-small cell lung carcinoma.